Quantcast

Latest Sipuleucel-T Stories

2011-01-06 15:00:00

SEATTLE, Jan. 6, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) management will host a conference call on Friday, January 7, 2011 at 9:00 a.m. ET to provide updates on U.S.

2011-01-06 12:38:00

SAN FRANCISCO, Jan. 6, 2011 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Opexa Therapeutics, Inc. (Nasdaq: OPXA) and raised its twelve month target price from $4.40 to $6.50.

2011-01-05 06:30:00

SEATTLE, Jan. 5, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2011 at 11:30 a.m. PT.

2010-12-08 06:30:00

SEATTLE, Dec. 8, 2010 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the 2010 Deutsche Bank BioFEST conference in Boston on December 15, 2010 at 10:30 a.m. ET.

2010-11-18 13:51:00

Medicare Officials Will Consider the Panel's Endorsement When Deciding Whether Provenge Should Be Covered WASHINGTON, Nov. 18, 2010 /PRNewswire-USNewswire/ -- Provenge is one step closer to being covered by Medicare.

2010-11-16 06:30:00

WASHINGTON, Nov. 16, 2010 /PRNewswire/ -- Tomorrow is a landmark day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected.

2010-11-10 16:00:00

SEATTLE, Nov. 10, 2010 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that it has completed the submission of the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License Application for the Morris Plains, New Jersey manufacturing facility.


Word of the Day
logocentrism
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.
Related